Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Cheung

Dentist, Oral and Maxillofacial Surgery Oak Ridge, TN Doctor of Dentistry

NPI 1043234750 CMS profile 228233

140 E. Division Road, Suite A-1, Oak Ridge, TN 37830

Open in the dashboard

General payments

$7,990

169 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Cheung of Oak Ridge, TN is reported in the CMS Open Payments database as having received $7,990 across 169 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $237 7
2024 General $1,786 10
2023 General $1,011 23
2022 General $3,253 64
2021 General $405 20
2020 General $533 24
2019 General $766 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Cheung
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Andrew Cheung were reported at $237. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Andrew Cheung Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $766 $142 $50–$420 $163
2020 $533 $96 $36–$277 $114
2021 $405 $138 $45–$419 $132
2022 $3,253 $144 $48–$367 $149
2023 $1,011 $153 $55–$399 $160
2024 $1,786 $152 $50–$400 $164
2025 $237 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Dentsply Sirona Inc $2,568 56 payments
  2. Pacira Pharmaceuticals Incorporated $2,217 5 payments
  3. Straumann USA LLC $1,421 42 payments
  4. Smith+Nephew, Inc. $560 19 payments
  5. Southern Implants North America Inc $427 18 payments
  6. DENTSPLY IH Inc. $194 5 payments
  7. Zimvie Inc. $163 8 payments
  8. Zimmer Biomet Holdings, Inc. $120 4 payments
  9. BioHorizons Implant Systems Inc. $110 3 payments
  10. Stryker Corporation $109 3 payments
  11. Other $102 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,546 144 payments
  2. Honoraria $2,145 2 payments
  3. Travel and Lodging $1,022 5 payments
  4. Gift $184 16 payments
  5. Education $93 2 payments
Products named General payments · program years 2019–2025
  1. Implant Dentistry $2,303 44 payments
  2. Exparel $2,217 5 payments
  3. Zilretta $1,560 1 payment
  4. Iovera $1,560 1 payment
  5. ASTRA TECH Implant System Implant Dentistry $266 9 payments
  6. GRAFIX PL $257 12 payments
  7. STRAVIX Extremities & Limb Restoration $208 9 payments
  8. Stravix Other Advanced Wound Management $175 3 payments
  9. ASTRA TECH Implant System Implant Dentistry $168 7 payments
  10. TSX Implants $130 6 payments
  11. Other $1,254 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

777

Median for Oral Surgery (Dentist only): 288

Drug cost

$3,159

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

32%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 257 $1,218
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 220 $819
Ibuprofen Generic 138 $423
Clindamycin Hcl Generic 31 $207
Promethazine Hcl Generic 90 $170
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 14 $134
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 15 $102
Azithromycin Generic 12 $83

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zilretta
  • Pacira Pharmaceuticals Incorporated $520
$520 — —
Exparel
  • Pacira Pharmaceuticals Incorporated $520
$520 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record